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Abstract
Antimicrobial photodynamic therapy (aPDT) may be useful 
as a supportive antimicrobial measure for caries-active sub-
jects. In this study, the antimicrobial efficacy of aPDT with a 
phenalen-1-one photosensitizer was evaluated in a novel in 
vitro biofilm model comprising Actinomyces naeslundii, Acti-
nomyces odontolyticus, and Streptococcus mutans and was 
compared to chlorhexidine. The proposed biofilm model al-
lows high-throughput screening for antimicrobial efficacy 
while exhibiting a differentiated response to different anti-
microbial approaches. While chlorhexidine 0.2% showed a 
reduction of ≈4 log10 for all species, aPDT led to a more pro-
nounced reduction of S. mutans (2.8 log10) than of Actinomy-
ces spp. (1.2 or 1.3 log10). A similar effect was also observed 
in monospecies biofilms. Therefore, aPDT may be more ef-
fective against S. mutans than against Actinomyces spp. 
when in biofilms, and this antimicrobial approach merits fur-
ther investigations. © 2018 S. Karger AG, Basel
According to the Global Burden of Disease 2015 study, 
dental caries was still found to be the most prevalent dis-
ease worldwide, affecting about 2.3 billion adults and 560 
million children [GBD 2015 Disease and Injury Incidence 
and Prevalence Collaborators, 2016], and, accordingly, 
may be considered as a major economic burden for pub-
lic health care [Sheiham, 2001]. With regard to the distri-
bution of dental caries, it is well known that there are sev-
eral disparities by social standing mostly because of dif-
ferences in diet, fluoride use, and social empowerment, 
resulting in a sub-population with strong caries incidence 
[Edelstein, 2006]. Therefore, the development of preven-
tion concepts for these high-risk patients remains a major 
goal.
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In this regard, supportive antimicrobial measures may 
be useful in daily oral hygiene practice additionally to me-
chanical removal of biofilms for caries-active patient sub-
groups [ten Cate, 2009]. The widely used antiseptic of 
choice is chlorhexidine (CHX), either applied as oral 
rinse or as gel or varnish [Walsh et al., 2015]. However, 
its actual impact on caries prevention is debated contro-
versially, and its use exhibits some undesirable side effects 
like yellow-brown staining of teeth and tongue and alter-
ing the sense of taste [Autio-Gold, 2008]. Furthermore, 
recently, its use has been recommended to be limited to 
“those applications with a clear patient benefit” (mostly 
in intensive care) for reducing the risk of inducing ac-
quired resistances to CHX or even cross-resistances to 
antibiotics in pathogens [Kampf, 2016]. Accordingly, 
Kitagawa et al. [2016] reported that repeated exposure of 
Enterococcus faecalis to CHX resulted in drug resistance, 
as demonstrated by increased minimum inhibitory con-
centrations.
In this instance, antimicrobial photodynamic therapy 
(aPDT) may be a promising alternative [Gursoy et al., 
2013; Wainwright et al., 2017]. aPDT is a 3-component 
system, consisting of a per se nontoxic dye (photosensi-
tizer [PS]), light of an appropriate wavelength, and mo-
lecular oxygen. When the PS molecule is activated by 
light, it is transmitted to an excited state, from which 
there are 2 mechanisms to regain its ground state: in type 
I mechanism, the charge is transferred to a substrate or 
molecular oxygen resulting in emergence of oxygen radi-
cals, such as superoxide ions and hydroxyl radicals or hy-
drogen peroxide. In type II mechanism, energy is trans-
ferred to molecular oxygen, resulting in the generation of 
singlet oxygen (1O2), which is regarded as the most effec-
tive reactive oxygen species [Wainwright, 1998; Cieplik et 
al., 2014; Wainwright et al., 2017]. Hereby, the singlet ox-
ygen quantum yield ΦΔ describes the proportion of type 
II mechanism [Maisch et al., 2007]. Due to its unselective 
mechanism of action, the potential of resistance towards 
aPDT is very unlikely [Giuliani et al., 2010; Tavares et al., 
2010], especially for type II mechanism [Cieplik et al., 
2013]. Accordingly, PS based on a phenalen-1-one struc-
ture seem to be particularly advantageous due to their 
high singlet oxygen quantum yield ΦΔ ≥ 0.95 [Cieplik et 
al., 2013; Späth et al., 2014; Tabenski et al., 2016]. Further-
more, for oral application, esthetic compromises for pa-
tients will not be an issue due to the tooth-like color of 
phenalen-1-one derivatives [Späth et al., 2014].
However, before any clinical application, it is manda-
tory to evaluate novel antimicrobial approaches for their 
efficacy against biofilms, as it is well known that bacteria 
embedded in biofilms exhibit strongly enhanced toler-
ance for antimicrobial challenges as compared to their 
planktonic counterparts [Marsh, 2004]. Accordingly, it is 
of vital importance to develop in vitro biofilm models that 
are easy to operate and allow high-throughput screening 
of given antimicrobial compounds or approaches.
The aim of the present study was to evaluate the anti-
microbial efficacy of phenalen-1-one-mediated aPDT on 
a novel polymicrobial biofilm model cultured from car-
ies-associated bacteria in vitro in comparison to the gold-
standard antiseptic CHX.
Materials and Methods
Chemicals and Light Source
The PS used in this study was 2-((4-pyridinyl)methyl)-1H-phe-
nalen-1-one chloride and had been synthetized at the Department 
of Organic Chemistry (University of Regensburg, Germany), as 
described earlier in detail (purity ≥99%) [Cieplik et al., 2013; Späth 
et al., 2014]. PS suspensions were freshly prepared for the experi-
ments and stored in the dark at 4  ° C for no longer than 2 weeks. 
For irradiation of the PS, a gas discharge lamp (Waldmann PIB 
3000; Waldmann Medizintechnik, Villingen-Schwenningen, Ger-
many) was employed (λem 380–600 nm). Irradiance was adjusted 
to 50 mW/cm2 at sample level, resulting in an energy dose of 30 J/
cm2 for an irradiation period of 10 min. CHX digluconate dis-
solved in distilled water was prepared by the pharmacy department 
of the University Medical Center Regensburg yielding concentra-
tions of 0.2 and 2%.
Bacterial Culture and Biofilm Formation
Three reference strains, Actinomyces naeslundii (DSM-
43013), Actinomyces odontolyticus (DSM-19120), and Strepto-
coccus mutans (DSM-20523), were obtained from DSMZ 
(Deutsche Sammlung von Mikroorganismen und Zellkulturen, 
Braunschweig, Germany) to be used in this study. Bacteria were 
grown and maintained on Columbia Agar plates (provided by the 
Institute for Microbiology and Hygiene, University Medical Cen-
ter Regensburg, Regensburg, Germany) in a microincubator 
(MI23NK, SCHOLZEN Microbiology Systems, Necker, Switzer-
land) under anaerobic conditions (80% N2, 10% CO2, 10% H2). 
Modified Fluid Universal Medium (mFUM) supplemented with 
67 mmol/L Sørensen’s buffer (pH 7.2) and containing carbohy-
drate (0.15% [w/v] glucose and 0.15% [w/v] sucrose) was em-
ployed as a basal liquid medium [Gmür and Guggenheim, 1983; 
Guggenheim et al., 2001]. For preparation of planktonic cultures, 
colonies were picked and suspended in 5 mL of mFUM with 0.5 
mL fetal bovine serum (FBS; Gibco® Life Technologies, Carls-
bad, CA, USA) for 24 h under anaerobic conditions to obtain 
bacteria in the stationary growth phase. Afterwards, suspensions 
were harvested by centrifugation (ROTINA 420 R, Hettich Lab 
Technology, Tuttlingen, Germany) and resuspended in mFUM 
yielding an optical density of 1.0, as measured by means of a spec-
trophotometer (Ultrospec 3300 pro, Amersham Biosciences, 
Amersham, UK). Bacterial suspensions were diluted 1: 9 in the 
biofilm culture medium (BCM) consisting of 50% mFUM, 10% 
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FBS, and 40% whole unstimulated human saliva (saliva) that had 
been pooled from 2 volunteers (authors F.W. and D.M.) and ster-
ile-filtered (pore size: 0.2 µm; Acrodisc® Syringe Filters, Pall Cor-
poration, Newquay, UK).
Polyspecies biofilms were formed in 96-well polystyrene cul-
ture plates (Corning® Costar®, Corning, NY, USA). For simula-
tion of pellicle coating, wells were incubated with saliva for 2 h 
at room temperature. After that, saliva was discarded, and wells 
were filled with 200 μL of BCM containing A. naeslundii and A. 
odontolyticus and incubated under anaerobic conditions. After 
16 h, medium was carefully removed and 200 μL fresh BCM con-
taining S. mutans was added. After 48 h, a further medium 
change was performed, and biofilms were incubated for another 
24 h.
Formation of monospecies biofilms was performed according-
ly: after a 2-h incubation with saliva, wells were filled with 200 μL 
of BCM containing A. naeslundii, A. odontolyticus, or S. mutans, 
respectively. Medium changes were after 24 and 48 h. In all cases, 
the total culture period was 72 h.
Antimicrobial Assay
After 72 h, medium was carefully discarded from the wells and 
the biofilms were either incubated with phosphate-buffered saline 
(PBS; Biochrom, Berlin, Germany; groups PS– L–, PS– L+) or PS 
(groups PS+ L–, PS+ L+), respectively, in the dark for 10 min and 
then illuminated for another 10 min or incubated with CHX 0.2% 
or CHX 2% for a total of 20 min (50 μL each). Immediately after-
wards, PBS, PS, or CHX was carefully removed, and each biofilm 
was brought to suspension with 200 μL of PBS and transferred to 
an Eppendorf tube. These were placed in an ultrasonic water bath 
chamber (Sonorex Super RK 102 H, Bandelin, Berlin, Germany) 
obtaining a frequency of 35 kHz for 10 min and then vortexed 
(REAX top, Heidolph Instruments, Schwabach, Germany) for 5 s 
to separate aggregated bacteria. Ten-fold serial dilutions (10–2 to 
10–7) were prepared in PBS, and aliquots (180 μL) were plated on 
Columbia blood agar and incubated anaerobically for 72 h. After-
wards, colony-forming units (CFU) were evaluated. For polyspe-
cies biofilms, bacteria on agar plates were differentiated by their 
respective colony morphology.
Data Analysis
All results are shown as medians and neighboring quartiles 
(25/75% percentiles) and were calculated using SPSS for Windows, 
version 23 (SPSS Inc., Chicago, IL, USA), from the values of at least 
6 independent experiments, each performed in duplicate. Hori-
zontal dotted and dashed lines represent reductions of 3 and 5 log10 
steps of CFU, respectively, compared to the matching untreated 
control group PS– L–. Medians on or below these lines demon-
strate antimicrobial efficacy of at least 99.9% (3 log10) or 99.999% 
(5 log10), respectively, which is declared as biologically relevant 
antimicrobial activity or disinfectant effect according to the guide-
lines of infection control [Boyce and Pittet, 2002].
Results
Antimicrobial Efficacy against Polyspecies Biofilms
Untreated polyspecies biofilms (PS– L–) showed a 
slight overgrowth of S. mutans (4.7 × 107) of ≈1 log10 step 
as compared to A. naeslundii (3.8 × 106) and A. odonto-
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Fig. 1. Antimicrobial efficacy on polyspecies 
biofilms. All results are shown as medians 
and neighboring quartiles (25/75% percen-
tiles) depicted on a log10-scaled ordinate. 
The left panel shows absolute CFU data of 
untreated control groups (PS– L–) exhibit-
ing overgrowth of Streptococcus mutans of 
≈1 log10 as compared to both Actinomyces 
spp. The right panel depicts relative CFU 
data with untreated controls (groups PS– 
L–) set to 100%. Horizontal dotted and 
dashed lines represent CFU reductions of 3 
log10 and 5 log10, respectively, as compared 
to untreated control groups (PS– L–). There 
was no effect of light (PS– L+) or PS alone 
(PS+ L–). aPDT (PS+ L+) led to higher CFU 
reduction of S. mutans (2.8 log10) than of A. 
naeslundii (1.2 log10) and A. odontolyticus 
(1.3 log10). CHX 0.2% reduced CFU of S. 
mutans by 4.0 log10, CFU of A. naeslundii by 
4.5 log10, and CFU of A. odontolyticus by 3.8 
log10. CHX 2% led to a reduction of CFU by 
> 6 log10 below the detection limit. CFU, col-
ony-forming units; PS, photosensitizer; L, 
light; aPDT, antimicrobial photodynamic 
therapy; CHX, chlorhexidine.
Co
lor
 ve
rsi
on
 av
ail
ab
le 
on
lin
e
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
E-
M
ed
ie
n 
   
   
   
   
   
   
   
   
 
13
0.
60
.4
7.
19
2 
- 1
1/
29
/2
01
8 
3:
14
:4
6 
PM
Cieplik/Wimmer/Muehler/Thurnheer/
Belibasakis/Hiller/Maisch/Buchalla
Caries Res 2018;52:447–453450
DOI: 10.1159/000487815
lyticus (4.3 × 106). The left panel of Figure 1 shows abso-
lute CFU values of untreated controls, while the right 
panel depicts relative CFU data with untreated controls 
(groups PS– L–) set to 100%.
aPDT reduced CFU of S. mutans (2.8 log10) more than 
CFU of A. naeslundii and A. odontolyticus (1.2 or 1.3 
log10, respectively), while treatment with PS (PS+ L–) or 
light alone (PS– L+) had no effect. CHX 0.2% reduced 
CFU of all species by ≈4 log10 steps (S. mutans: 4.0 log10; 
A. naeslundii: 4.5 log10; A. odontolyticus: 3.8 log10), while 
CHX 2% led to eradication by > 6 log10 below the detec-
tion limit.
Antimicrobial Efficacy against Monospecies Biofilms
Untreated monospecies biofilms (groups PS– L–) 
showed growth of 2 × 108, 4 × 107, and 1 × 106 CFU for S. 
mutans, A. naeslundii, and A. odontolyticus, respectively. 
Figure 2 shows relative CFU data with untreated controls 
(groups PS– L–) set to 100%.
CFU reductions for aPDT (PS+ L+) were 3.0 log10 for 
S. mutans, while A. naeslundii and A. odontolyticus were 
reduced by 2.5 log10 or 1.1 log10 only. In contrast, CHX 
0.2% led to reduction rates of 4.3 log10 for S. mutans and 
A. odontolyticus, while CFU of A. naeslundii were re-
duced by 6.0 log10. Treatment with PS (PS+ L–) or light 
only (PS– L+) had no effect in any cases.
Discussion
The aim of the present study was to investigate the an-
timicrobial efficacy of phenalen-1-one-mediated aPDT 
as compared to the gold-standard antiseptic CHX for in-
activation of biofilms from cariogenic bacteria in vitro. 
For this purpose, a novel biofilm model for high-through-
put screening of antimicrobial approaches was estab-
lished comprising A. naeslundii, A. odontolyticus, and S. 
mutans. A. naeslundii is considered to be an essential ear-
ly colonizer in dental plaque [Dige et al., 2009], while A. 
odontolyticus is suggested to be a key organism mediating 
adhesion and co-aggregation in supragingival plaque 
[Tang et al., 2003] and is associated with high caries inci-
dence in children [ElSalhy et al., 2016]. S. mutans is well 
known to play a major role in the pathogenesis of dental 
caries, mostly due to its ability to produce an insoluble 
polymeric matrix and due to its acidogenic and aciduric 
properties [Klein et al., 2015].
The culture conditions for this biofilm model have 
been modified from the Zurich biofilm model of supra-
gingival plaque originally described by Guggenheim et al. 
[2001]: instead of pasteurization of human saliva, filter 
sterilization was employed because the latter is deemed to 
be preferable in terms of protein integrity [Ruhl et al., 
2011]. Furthermore, concentrations of carbohydrates in 
mFUM were changed from 0.15% glucose to 0.15% su-
crose and 0.15% glucose each, since S. mutans requires 
CF
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Fig. 2. Antimicrobial efficacy on monospe-
cies biofilms. All results are shown as me-
dians and neighboring quartiles (25/75% 
percentiles) depicted on a log10-scaled or-
dinate as relative CFU data with the respec-
tive untreated controls (groups PS– L–) set 
to 100%. Horizontal dotted and dashed 
lines represent CFU reductions of 3 log10 
and 5 log10, respectively, as compared to 
the respective untreated control groups 
(PS– L–). There was no effect of light (PS– 
L+) or PS alone (PS+ L–). aPDT (PS+ L+) 
led to CFU reductions of 3.0 log10 for S. mu-
tans biofilms, while CFU in A. naeslundii 
and A. odontolyticus biofilms were reduced 
by 2.5 log10 or 1.1 log10, respectively. CHX 
0.2% reduced CFU in S. mutans and A. 
odontolyticus biofilms by 4.3 log10 and in A. 
naeslundii biofilms by 6.0 log10. CFU, col-
ony-forming units; PS, photosensitizer; L, 
light; aPDT, antimicrobial photodynamic 
therapy; CHX, chlorhexidine.
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sucrose for glucosyltransferase-mediated synthesis of 
exopolysaccharides [Kreth et al., 2008; Koo et al., 2010], 
while Actinomyces spp. preferentially utilize glucose for 
their metabolism via the Embden-Meyerhof-Parnas 
pathway [Takahashi and Yamada, 1999]. Proportions of 
mFUM, saliva, and FBS in the BCM were adjusted to 50, 
40, and 10%, respectively, for increasing biofilm density 
and sturdiness [Ammann et al., 2012]. In contrast to the 
Zurich biofilm model, biofilms were cultured in 96-well 
plates rather than on hydroxyapatite discs placed in 24-
well plates for ensuring optimal experimental conditions 
for antimicrobial evaluation of light-based approaches 
like aPDT. Otherwise, biofilms growing on both sides of 
the hydroxyapatite discs may have impeded standardized 
irradiation procedures. Biofilm culture was started with 
A. naeslundii and A. odontolyticus, while S. mutans was 
added after 24 h of culture for preventing outgrowth of 
this species with respect to the slower cell division of Ac-
tinomyces spp. relative to streptococci [Dige et al., 2009]. 
Accordingly, it was recently shown that, when Streptococ-
cus oralis is absent, S. mutans dominates the Zurich bio-
film at the expense of Actinomyces oris [Thurnheer and 
Belibasakis, 2018]. Furthermore, S. mutans colonizes in 
vitro much less efficiently on streptococcal biofilms than 
on A. naeslundii biofilms [Wang et al., 2011].
As compared to the Zurich biofilm model of supragin-
gival plaque and its various modifications comprising up 
to 11 bacterial or fungal species [Guggenheim et al., 2001; 
Shapiro et al., 2002; Ammann et al., 2012; Belibasakis and 
Thurnheer, 2014], this biofilm model is less complex in 
terms of species diversity but, on the other hand, allows 
easy and high-throughput screening while still being ro-
bust to antimicrobial challenge. Treatment with CHX 
2.0% for 20 min served as a positive control leading to 
total eradication of biofilm bacteria below detection lim-
it. In contrast, treatment with CHX 0.2% resulted in a re-
duction of ≈4 log10 steps, while shorter treatment periods 
exhibited substantially lower inactivation rates (data not 
shown). This is in line with the literature, where Wilson 
[1996] reported no antimicrobial effect of CHX 0.2% after 
treating 72-h old S. mutans biofilms for 5 min but eradi-
cation by > 6 log10 below detection limit after treatment 
for 60 min. Likewise, Voos et al. [2014] found inactivation 
of ≈1 log10 after treating biofilms formed in situ with 
CHX 0.2% for 3 min, while Hoogenkamp et al. [2009] 
showed ≈2 log10 inactivation of S. mutans biofilms after 
treatment for 5 min. In general, there is a strong and cru-
cial correlation between treatment period and antimicro-
bial efficacy, especially when it comes to biofilms [Mah 
and O’Toole, 2001; Stewart and Costerton, 2001]. Diffu-
sion of given antimicrobials into deeper layers of the bio-
film may be hampered or slowed by interaction of these 
positively charged molecules with the negatively charged 
residues of the biofilm’s extracellular polymeric sub-
stance [Thurnheer et al., 2003; Tseng et al., 2013]. There-
fore, shorter treatment periods may just lead to killing of 
bacteria in the superficial layers of the biofilm, as it has 
been shown in the classic study by Zaura-Arite et al. 
[2001].
Treatment with aPDT led to less pronounced inactiva-
tion rates as compared to CHX. S. mutans was inactivated 
by 2.8 log10, while A. naeslundii and A. odontolyticus ex-
hibited killing rates of 1.2 or 1.3 log10 only. It is notewor-
thy to say that despite an identical total treatment period 
of 20 min (10 min of incubation in the dark followed by 
10 min of irradiation), the period of antimicrobial activ-
ity of aPDT is limited to the time when the light is switched 
on. Interestingly, although aPDT is known to be an un-
selective antimicrobial approach [Wainwright et al., 
2017], S. mutans exhibited noticeably higher susceptibil-
ity to phenalen-1-one-mediated aPDT as compared to 
both A. naeslundii and A. odontolyticus. The influence of 
subsequent addition of S. mutans, potentially leading to 
only superficial colonization of this species within the 
biofilm, can be ruled out because, in this instance, S. mu-
tans would have been inactivated more severely than both 
Actinomyces spp. in the CHX groups, too. The higher sus-
ceptibility of S. mutans to aPDT was further substantiated 
by investigating antimicrobial efficacy in monospecies 
biofilms of all 3 species. Likewise, aPDT showed higher 
inactivation efficacy in S. mutans biofilms (3.0 log10) as 
compared to A. naeslundii (2.5 log10) and A. odontolyticus 
(1.1 log10) biofilms. These results are in contrast to a pre-
vious study where aPDT with the same PS as used in the 
present study resulted in a 6.5 log10 inactivation against 
A. naeslundii monospecies biofilms [Cieplik et al., 2015]. 
However, this difference in antimicrobial efficacy may be 
due to employing a distinct strain (A. naeslundii T14V) 
and due to the longer incubation period (25 min) [Cieplik 
et al., 2015], again elucidating the crucial impact of treat-
ment period.
Actinomyces spp. are generally known for their thick 
and robust cell walls, which are resistant to salivary lyso-
zyme and other peptidoglycan-hydrolyzing enzymes 
[Delisle et al., 2006]. Therefore, the higher tolerance to 
aPDT may be due to an insufficient permeability for PS 
molecules through the cell membrane, as suggested by 
Dige et al. [2009] as a cause for the irregular distribution 
of fluorescent signals when applying FISH to A. naeslun-
dii. Furthermore, Actinomyces spp. tend to cluster togeth-
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er [Dige et al., 2009] and may even be encapsulated by 
streptococci, as it has been proposed by Bos et al. [1996].
To the best of our knowledge, there are no other re-
ports in the literature on the effects of aPDT on polymi-
crobial biofilms formed in vitro from caries-associated 
species, such as S. mutans and Actinomyces spp. There-
fore, the higher tolerance of Actinomyces spp. to phenal-
en-1-one-mediated aPDT found here may justify more 
detailed investigation in future studies, e.g., by using flow 
cytometry for the investigation of membrane alterations. 
This phenomenon merits further investigation, as it may 
be utilized clinically by repeated application of aPDT to 
induce a shift from highly cariogenic streptococci-domi-
nated to less cariogenic Actinomyces-dominated micro-
biota in caries-active patients, which may be an interest-
ing approach for biofilm modulation in view of the eco-
logical plaque hypothesis [Marsh et al., 2015].
However, before any clinical application of phenalen-
1-one-mediated aPDT, potential harmful effects on 
mammalian tissues must be ruled out. As a first step, in a 
recent study, aPDT with several phenalen-1-one deriva-
tives was investigated for its antimicrobial efficacy in 
planktonic cultures of dermal pathogens and for its eu-
karyotic toxicity for keratinocytes as compared to the bio-
cide benzalkonium chloride in order to evaluate a poten-
tially effective concentration range (i.e., ≥5 log10 steps re-
duction of CFU while ≥80% survival of keratinocytes) 
[Muehler et al., 2017]. For the PS used in the present 
study, no harmful effects were found in the dark. In com-
bination with light, there was a broad effective concentra-
tion range, while for benzalkonium chloride no effective 
concentration range could be found at all [Muehler et al., 
2017]. Although these results are encouraging, further 
biocompatibility studies will be necessary to establish the 
clinical safety of phenalen-1-one-mediated aPDT.
Conclusion
In this study, a novel caries biofilm model is described 
comprising A. naeslundii, A. odontolyticus, and S. mu-
tans, which allows easy and high-throughput screening of 
given compounds or approaches while exhibiting sturdi-
ness towards antimicrobial challenges. While treatment 
with CHX 0.2% inactivated all species by ≈4 log10 steps, 
phenalen-1-one-mediated aPDT led to more pronounced 
inactivation of S. mutans (2.8 log10) as compared to A. 
naeslundii (1.2 log10) and A. odontolyticus (1.3 log10), 
which was similarly found in monospecies biofilms.
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